Safety and Immunogenicity of VLA2001 Adults Aged ≥56 Years

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a A Phase III, Open label, Multicenter, Single Arm Study to assess the Safety, Tolerability and Immunogenicity of VLA2001 in volunteers aged ≥ 56 years. Approximately 300 participants are enrolled in a non-randomized manner.
Epistemonikos ID: d5faf3a0905d50d0d6b35cc2515eac68effbb0c9
First added on: Jul 10, 2021